{"id":52097,"date":"2025-10-10T08:46:09","date_gmt":"2025-10-10T08:46:09","guid":{"rendered":"https:\/\/www.europesays.com\/se\/52097\/"},"modified":"2025-10-10T08:46:09","modified_gmt":"2025-10-10T08:46:09","slug":"tilen-trselic-tilldelas-2025-ars-cilla-weigelt-stipendium","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/52097\/","title":{"rendered":"Tilen Trselic tilldelas 2025 \u00e5rs Cilla Weigelt-stipendium"},"content":{"rendered":"<p><strong>Om Cilla Weigelt<\/strong><\/p>\n<p>Cecilia \u201cCilla\u201d Weigelt (f\u00f6dd Gidl\u00f6f) disputerade i klinisk immunologi vid Uppsala universitet 1998. \u00c5r 2000 b\u00f6rjade hon p\u00e5 det dansk-svenska bioteknikf\u00f6retaget HemeBiotech som chef f\u00f6r cellbiologi. Hon stannade kvar i f\u00f6retaget (senare omd\u00f6pt till Zymenex, som senare f\u00f6rv\u00e4rvades av Chiesi Group 2013) under hela sin karri\u00e4r.\u00a0<\/p>\n<p>Under denna tid gav hon betydande bidrag till flera l\u00e4kemedelsuppt\u00e4ckts- och utvecklingsprojekt inriktade p\u00e5 behandling av s\u00e4llsynta sjukdomar. Cilla st\u00f6ttade alltid yngre forskare och drevs av att hj\u00e4lpa patienter som saknade adekvat behandling f\u00f6r f\u00f6r\u00f6dande sjukdomar. Cilla Weigelt gick bort 2021 vid 51 \u00e5rs \u00e5lder efter att ha levt tio \u00e5r med br\u00f6stcancer.<\/p>\n<p><strong>Om Cilla Weigelt-priset\u00a0<\/strong><\/p>\n<p>Cilla Weigelt-priset har instiftats av hennes arbetsgivare Chiesi, Structural Genomics Consortium (SGC) samt av v\u00e4nner och familj i hennes anda f\u00f6r att st\u00f6dja och inspirera unga doktorander och f\u00f6r att hedra hennes minne.\u00a0<\/p>\n<p>Priset administreras av Stiftelsen Centrum f\u00f6r Molekyl\u00e4r Medicin (CMM) vid Karolinska Institutet och Karolinska Universitetssjukhuset.<strong>\u00a0<\/strong>Ytterligare bidrag till priset har l\u00e4mnats av Aled Edwards (Toronto, Kanada), Johan Weigelt (Stockholm) och MRCS AB (Michael Sundstr\u00f6m, Stockholm).<\/p>\n","protected":false},"excerpt":{"rendered":"Om Cilla Weigelt Cecilia \u201cCilla\u201d Weigelt (f\u00f6dd Gidl\u00f6f) disputerade i klinisk immunologi vid Uppsala universitet 1998. \u00c5r 2000&hellip;\n","protected":false},"author":2,"featured_media":52098,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[113,112,34,31,33,32,30],"class_list":{"0":"post-52097","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-halsa","8":"tag-halsa","9":"tag-health","10":"tag-se","11":"tag-svenska","12":"tag-sverige","13":"tag-sweden","14":"tag-swedish"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/52097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=52097"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/52097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/52098"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=52097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=52097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=52097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}